Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2014
03/05/2014CN102895386B Method for performing extraction on angelica dahurica, common cnidium fruit, Chinese red pepper and elecampane inula root and pharmaceutical application
03/05/2014CN102895213B Stable cefotiam hexetil hydrochloride composition
03/05/2014CN102864157B Immune protective antigen of haemophilus parasuis
03/05/2014CN102838623B Cefminox sodium compound crystal, preparation method of cefminox sodium compound crystal and sterile powder injection containing cefminox sodium compound crystal
03/05/2014CN102836318B Washing liquid for gardnerella vaginitis
03/05/2014CN102836247B Tangerine extract composition for feminite care
03/05/2014CN102813626B Amorphous form cefmenoxime hydrochloride compound combination for injection
03/05/2014CN102772764B Nursing traditional Chinese medicine disinfectant and preparation method
03/05/2014CN102772747B Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis
03/05/2014CN102772420B Swine bile phthalate eye drops and preparation method thereof
03/05/2014CN102731344B Hydrazine nitrile cathepsin inhibitors with different P<3> structures, and application thereof
03/05/2014CN102727605B Oral liquid for treating vital myocarditis
03/05/2014CN102702351B Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof
03/05/2014CN102697895B Method for continuously extracting total polyphenol, chlorogenic acid and phlorizin from green apples
03/05/2014CN102671102B Traditional Chinese medicine composition for treating chronic hepatitis B
03/05/2014CN102617712B Polypeptide for effectively restraining activity of influenza virus polymerase
03/05/2014CN102603964B Water-soluble polymer iron chelator as well as preparation method and application thereof
03/05/2014CN102585034B Method for sulfonating pectin
03/05/2014CN102580115B Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine
03/05/2014CN102558126B 2-substituted chromone compound, as well as preparation method and application thereof
03/05/2014CN102414199B Diaryl ethers
03/05/2014CN102380101B Pholcodine-containing compound pharmaceutical preparation for treating cold
03/05/2014CN102307890B Hepatitis c virus inhibitors
03/05/2014CN102178604B Device and method for preparing gel microsphere and gel microsphere in which antitubercular agents can be injected
03/05/2014CN102172262B Enzyme treatment for infection
03/05/2014CN102106842B Levofloxacin hydrochloride micropill capsule and preparation method thereof
03/05/2014CN102048677B Valganciclovir Hydrochloride solid preparation and preparation method thereof
03/05/2014CN101951762B Foam stabilizer composition
03/05/2014CN101795713B Conjugate purification
03/05/2014CN101785779B Separation and preparation of isovaleryl-spiramycin II
03/05/2014CN101248038B Crystalline solid forms of tigecycline and methods of preparing same
03/05/2014CN101166828B Enzymatic production of peracids using perhydrolytic enzymes
03/04/2014US8666680 Recombinant soluble FC receptors
03/04/2014US8664382 Antibacterial compositions comprising metal phthalocyanine analogues
03/04/2014US8664360 BSL3 polypeptides
03/04/2014US8664224 External preparation for athlete's foot treatment
03/04/2014US8663916 Methods for producing antifungal bifunctional molecules for treating fungal infection
03/04/2014US8663656 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
03/04/2014US8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereof
03/04/2014CA2551644C Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof
03/04/2014CA2533918C Use of adcc-optimized antibodies for treating weak patients
03/04/2014CA2444164C Pufa polyketide synthase systems and uses thereof
02/2014
02/27/2014WO2014030801A1 Novel anti-fungal peptide pg-2 derived from gogu valley potato, and use thereof
02/27/2014WO2014030020A1 Therapeutic bacteriophages
02/27/2014WO2014029498A1 Bixiamycins and sulfonylbixiamycins
02/27/2014WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/27/2014WO2014002035A3 A human monoclonal antibody against the vp1 protein of jc virus
02/27/2014WO2013188870A3 IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
02/27/2014US20140057869 Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use
02/27/2014US20140057863 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
02/27/2014US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions
02/27/2014US20140056947 Virus traps
02/27/2014US20140056927 Lipotheichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
02/27/2014US20140056923 Method of treating hypertension disorder and a pharmaceutical agent
02/27/2014US20140056922 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
02/27/2014US20140056809 Treatment and diagnosis of macrophage mediated disease
02/27/2014CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/26/2014EP2700638A1 Purine analogs
02/26/2014EP2700412A1 PROBIOTICS, SECRETORY IgA AND INFLAMMATION
02/26/2014EP2700411A1 Probiotics, secretory IgA and infection
02/26/2014EP2700409A1 IL-27 for modulation of immune response in acute lung disease
02/26/2014EP2700407A1 Granules in liquid dosage form
02/26/2014EP2700406A1 METHOD FOR PRODUCING POLYGONUM TINCTORIUM EXTRACT& xA;
02/26/2014EP2699595A1 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity
02/26/2014EP2699573A2 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1h-imidazo[4,5-c]quinoline derivatives
02/26/2014EP2699566A1 Phenyl-isoxazol derivatives and preparation process thereof
02/26/2014EP2699558A1 Benzothiazole compounds and their pharmaceutical use
02/26/2014EP2699557A1 Aromatic amides and uses thereof
02/26/2014EP2699257A1 Peptide and conjugate vaccines for fungal infections
02/26/2014EP2699246A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
02/26/2014EP2699241A1 Antiviral compounds
02/26/2014EP2699239A2 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
02/26/2014EP2699238A2 Antiviral compositions directed against the influenza virus nucleoprotein
02/26/2014CN103608020A Method of treating dengue fever
02/26/2014CN103608014A Use of kinase inhibitors in preventing and treating inflammatory disorder
02/26/2014CN103608008A Non-leaching antimicrobial wound dressing
02/26/2014CN103608006A New combination comprising N-acetyl-L-cysteine and its use
02/26/2014CN103602689A Development of dengue virus vaccine components
02/26/2014CN103602639A Method of harvesting viruses by low-osmotic-pressure harvest liquid
02/26/2014CN103602638A Recombinant equine influenza virus strain, preparation method thereof and vaccine prepared from recombinant equine influenza virus strain
02/26/2014CN103602629A Methods for culturing swine testis cell in serum-free manner and producing classical swine fever cell vaccine by using swine testis cell
02/26/2014CN103602614A Preparation and application of composite microecological feed additive
02/26/2014CN103601828A Complex polymer and applications thereof
02/26/2014CN103601809A HCV multi-epitope peptide, truncated NS3, and DC activating molecule EDA recombinant protein vaccine and applications thereof
02/26/2014CN103601800A Mono- and di-PEG IL-10 production, and uses
02/26/2014CN103601795A Scylla paramamosain anti-fungal anti-lipopolysaccharide factor, as well as preparation method and application thereof
02/26/2014CN103601787A Glycyrrhizic acid derivative and synthesis method thereof
02/26/2014CN103601727A Use of novel amine compound modified protoporphyrin
02/26/2014CN103601724A Novel oxazolidinone compound, as well as preparation method and application thereof
02/26/2014CN103601721A 3-furylbis(benzodiazepine)-1-one series derivatives, and preparation method and application thereof
02/26/2014CN103601690A 3-phenylbis(benzodiazepine)-1-one series derivatives, and preparation method and application thereof
02/26/2014CN103601683A Benzohetercyclic compounds, preparation method thereof and applications thereof
02/26/2014CN103601676A Synthetic method for high-enantioselectivity N-acetyl-2-substitued-2, 3-dihydro-4-quinolinone compounds
02/26/2014CN103601670A Piplartine analogue, and preparation method and application thereof
02/26/2014CN103601663A Tryptamine derivative compound and preparation method and purpose thereof
02/26/2014CN103601621A Schisandrin and pharmaceutical application thereof
02/26/2014CN103599594A Device for treating nodule in breast
02/26/2014CN103599538A Preparation method of polymer nanoparticles containing antiretroviral drugs
02/26/2014CN103599535A External ointment prepared from i26 immune egg powder and traditional Chinese medicine decoction
02/26/2014CN103599534A Preparation method and use of poultry vaccine-specific pig spleen transfer factor
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 1798